Our latest article in the latest edition of the renowned magazine PLMEA (Poultry & Livestock Middle East & Africa)  highlights one of our latest innovations: BactiCid®NG, a next-generation feed additive designed to optimize gut health and performance in poultry.

The article, written by Valerie Daher, product manager at UTRIX, addresses that in today’s rapidly evolving poultry industry, gut health is regarded as the cornerstone of productivity, welfare, and sustainability. The gastrointestinal tract (GIT) not only governs nutrient digestion and absorption, but also plays a central role in immune function and disease prevention. “For producers, ensuring that birds maintain a balanced and functional GIT is critical to achieving optimal performance and profitability. However, the transition away from antibiotic growth promoters (AGPs) has made this task increasingly complex, especially in the Middle East”, Daher writes.

BactiCid®NG: Harnessing synergy through innovation

Among the most promising solutions are tributyrin and essential oils, two categories of feed additives that deliver multifaceted benefits when properly formulated and protected. Recognizing the complementary strengths of tributyrin and essential oils, UTRIX developed BactiCid®NG, a next-generation feed additive designed to optimize gut health and performance in poultry. BactiCid®NG leverages a unique blend of tributyrin with the essential oils carvacrol, thymol, and cinnamaldehyde. It comes in a powder, antibiotic-free premixture and has a recommended inclusion rate of 0.5 – 1.0 kg/T of feed (with higher dosages recommended for starter diets).

The distinguishing feature of BactiCid®NG lies in its UtriCAPS microencapsulation technology. Developed through years of research, this technology delivers several critical advantages:

• Targeted release: Active ingredients are protected from gastric degradation and released gradually in the intestine, where they are most effective.
• Enhanced stability: UtriCAPS maintains structural integrity under pelleting, extrusion, and storage conditions.
• Homogeneity and palatability: The technology ensures a uniform pearl-like texture with a soft odor, improving feed handling and animal acceptance.

BactiCid®NG, is based on robust science and is build for practical application. UTRIX trials demonstrated the superiority of its microencapsulation technology over competitor technologies. Whereas competing products released up to 90% of their active ingredients during gastric digestion, the product delivered controlled intestinal release, ensuring efficacy where it matters most (UTRIX Trials, 2023-2024).

Read more about BactiCid®NG here: https://www.utrix.com/product/bacticid_ng/. The full article can be read here (page 57): https://plmea.com/?page_id=493#flipbook-df_1956/57/